loading page

A retrospective analysis of recurrent pediatric ependymoma reveals extremely poor survival ind ineffectiveness of current treatments across central nervous locations and molecular subgroups.
  • Trggve Lundar,
  • Bernt Due-Tønnesen,
  • Radek Fric
Trggve Lundar
Oslo University Hospital
Author Profile
Bernt Due-Tønnesen
Oslo University Hospital
Author Profile
Radek Fric
Oslo University Hospital
Author Profile

Peer review status:ACCEPTED

26 May 2021Submitted to Pediatric Blood & Cancer
26 May 2021Submission Checks Completed
26 May 2021Assigned to Editor
03 Jun 2021Review(s) Completed, Editorial Evaluation Pending
03 Jun 2021Editorial Decision: Revise Minor
03 Jun 20211st Revision Received
03 Jun 2021Submission Checks Completed
03 Jun 2021Assigned to Editor
04 Jun 2021Review(s) Completed, Editorial Evaluation Pending
05 Jun 2021Editorial Decision: Accept